Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform cancer prevention and early detection options for their immediate blood relati
A prostate exam is a test that checks for early signs of prostate cancer. It doesn't reveal cancer, but if the test shows an abnormal result, your doctor will likely need to take a small sample of tissue from your prostate gland (biopsy) for further testing. There are two parts to a...
Practice Guidelines as TopicMaleDale W.doi:10.1038/nrurol.2012.115DaleWilliamNature Reviews UrologyDale W. Prostate cancer: PSA testing in older men--are we following the guidelines?. Nat Rev Urol 2012 ; 9:357 - 8; http://dx.doi.org/ 10.1038/nrurol.2012.115 ; PMID: 22641163...
The U.S. Preventive Services Task Force recommends that for men aged 55 to 69, the decision to have PSA testing should be an individual one based on a conversation about risks and benefits with their doctor. The American Cancer Society recommends a discussion between the doctor and patient abo...
Background Prostate-specific antigen (PSA) remains as the most used biomarker in the detection of early prostate cancer (PCa). Clinical practice guidelines (CPGs) are produced to facilitate incorporation of evidence into clinical practice. This is partic
The ZERO Prostate Cancer Support Community connects patients, families, friends and caregivers to enhance the quality of life for all those affected by prostate cancer. This community is sponsored by ZERO Prostate Cancer, an Inspire trusted partner.
Practical examples of application of French Onco-Urology guidelines on genetic testing in prostate cancer Current therapeutic developments in prostate cancer (PCa) tend to increasingly personalize the treatment strategy, in particular as a function of tumor gen... C Dariane - 《Progres En Urologie Jou...
2021 National Comprehensive Cancer Network(NCCN), All rights reserved. NCCN Guidelinesand this illustration may not be reproduced in any form without the express written permission of NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?) Prostate Cancer Version 2.2021 — February 17, ...
GU/Prostate Cancer : Review in-depth clinical information, latest medical news, and guidelines on prostate cancer and prostate cancer treatment including prostate cancer surgery. Learn about prostate cancer prognosis for advanced prostate cancer.
In summary, the 1997 revision of the ACS guideline for the early detection of prostate cancer is based on knowledge gained by a critical analysis of experience since the original version of 1992. This is only a milestone along a continuous journey rather than being the final destination. Other...